alexa Clinical Nanomedicine|omicsgroup|Journal Of Nanomedicine And Biotherapeutic Discovery

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Clinical Nanomedicine

Applications of nanotechnology for treatment, diagnosis, monitoring, and control of biological systems has recently been referred to as nanomedicine¬Ě by the National Institutes of Health. Research into the rational delivery and targeting of pharmaceutical, therapeutic, and diagnostic agents is at the forefront of projects in nanomedicine. These involve the identification of precise targets (cells and receptors) related to specific clinical conditions and choice of the appropriate nanocarriers to achieve the required responses while minimizing the side effects. Mononuclear phagocytes, dendritic cells, endothelial cells, and cancers (tumor cells, as well as tumor neovasculature) are key targets. Journals are the major source of knowledge for young and aspiring generations who are keen in pursuing their careers in science. This system provides easy access to networks of scientific journals. Authors who contribute their scholarly works to Open Access journals gain remarkable reputation as the research scholars explore these works extensively. This process assures considerable impact factor for the journal and good reputation to the authors that add value to their Academic Performance Index (API) Score. Because of the free access open access journals impact factors are improving.
 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords